Current controversies in the management of breast cancer Tusquets I, García-Estévez L, Adrover E, Calvo L, Alvarez I, García Mata J, Fernández Y, Margueli M, Seguí MA, Muñoz M, Rodríguez C, Rodríguez Lescure A, Colomer R, Gascón P, Martín M, Alba E, Barnadas A, Llombart A, Albanell J, Lluch A. Clinical & Translational Oncology 12 (4):278-86. FI: 1.146 (Q4) Treatment of cancer with oral drugs: a position statement by the Spanish society of medical oncology (SEOM) Colomer R, Alba E, Gonzalez-Martin A, Paz-Ares L, Martin M, Llombart A, Lescure Ar, Salvador J, Albanell J, Isla D, Lomas M, Rodriguez CA, Trigo JM, Germa JR, Bellmunt J, Tabernero J, Rosell R, Aranda E, Cubedo R, Baselga J. Annals of Oncology 21 (2): 196-198. FI: 5.647 (Q1) Bevacizumab plus low-dose metronomic oral cyclophosphamide in heavily pretreated patients with recurrent ovarian cancer Sánchez-Muñoz A, Mendiola C, Pérez-Ruiz E, Rodríguez-Sánchez CA, Jurado JM, Alonso-Carrión L, Ghanem I, de Velasco G, Quero-Blanco C, Alba E. Oncology 79:98-104. FI: 2.112 (Q3) Professional survey on knowledge and clinical patterns of pain management in Spanish medical oncology Escobar Y, Rodríguez CA, Caballero F, Reguero V, Camps C. Clinical & Translational Oncology 12: 819-824. FI: 1.146 (Q4) Interstitial Granulomatous Dermatitis with Arthritis associated with Trastuzumab Martín G, Cañueto J, Santos-Briz A, Alonso G, Unamuno PD, Cruz JJ. Journal of the European Academy of 24 (4): 493-4. FI: 2.787 (Q1) SEOM clinical guidelines for the treatment of head and neck cancer Mesia Nin R, Pastor Borgoñon M, Cruz Hernández JJ, Isla Casado D. Clinical & Translational Oncology 12 (11): 742-8. FI: 1.146 (Q4) SEOM clinical guidelines for the treatment of nasopharyngeal carcinoma Pastor Borgoñon M, Mesia Nin R, Cruz Hernández JJ, Isla Casado D. Clinical & Translational Oncology 12 (11): 749-52. FI: 1.146 (Q4) Molecular predictors of efficacy of adjuvant weekly paclitaxel in early breast cancer Martín M, Rodríguez-Lescure A, Ruiz A, Alba E, Calvo L, Ruiz-Borrego M, Santaballa A, Rodríguez CA, Crespo C, Abad M, Domínguez S, Florián J, Llorca C, Méndez M, Godes M, Cubedo R, Murias A, Batista N, García MJ, Caballero R, de Alava E. Breast Cancer Research and Treatment 123 (1):149-57. FI: 4.696 (Q1) Gemcitabine plus vinorelbine versus vinorelbine monotherapy in patients with metastatic breast cancer previously treated with anthracyclines and taxanes: final results of the phase III. Spanish Breast Cancer Research Group (GEICAM) trial Martín M, Ruiz A, Muñoz M, Balil A, García-Mata J, Calvo L, Carrasco E, Mahillo E, Casado A, García-Saenz JA, Escudero MJ, Guillem V, Jara C, Ribelles N, Salas F, Soto C, Morales-Vasquez F, Rodríguez CA, Adrover E, Mel JR, Spanish Breast Cancer Research Group (GEICAM) trial Lancet Oncology 8(3):219-25. FI: 14.470 (Q1) Recommendation of the scientific societies on the treatment of anaemia in cancer patients Rodríguez CA . Clinical & Translational Oncology 9(9):582-9. FI: 1.146 (Q4)
|
